DexCom posts Q3 revenue of $1.21 billion, beating estimates and raising 2025 guidance as analysts expect strong sales and margin improvement ahead.
Latest Ratings for DXCM
DateFirmActionFromTo Feb 2022Morgan StanleyMaintainsEqual-Weight Feb 2022BTIGUpgradesNeutralBuy Jan 2022Wells FargoUpgradesEqual-WeightOverweight